Major histocompatibility complex class II deficiency is a rare immunodeficiency disorder characterized by the absence or dysfunction of class II MHC molecules, leading to impaired T-cell activation and a heightened susceptibility to infections. This condition is critical for accurate diagnosis and management, as it informs treatment strategies and supports appropriate medical billing and public health reporting through ICD-10 Code D81.7.
ICD-10 Code D81.7 represents Major histocompatibility complex class II deficiency, a genetic disorder that affects the immune system's ability to respond to pathogens. This code should be used in clinical documentation and billing when diagnosing patients with this condition, ensuring accurate representation of the underlying immunodeficiency and facilitating appropriate treatment and management.
Major histocompatibility complex class II deficiency is primarily caused by genetic mutations affecting the expression of MHC class II molecules, which are essential for the activation of CD4+ T lymphocytes. The condition can lead to severe recurrent infections and requires prompt medical attention to manage complications effectively.
In SOAP notes, ICD-10 Code D81.7 is utilized to document the diagnosis of Major histocompatibility complex class II deficiency, aiding in the assessment of symptoms, treatment plans, and follow-up care. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.
ICD-10 Code D81.7 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Major histocompatibility complex class II deficiency. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Major histocompatibility complex class II deficiency often necessitates hospitalization for management of severe infections and immunological support. Treatment approaches may include:


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D81.7 is crucial for billing in hospital, emergency room, or infectious disease care settings, ensuring accurate representation of the patient's condition.
| CPT Code | Description |
|---|---|
| 96413 | Intravenous infusion, chemotherapy, requiring supervision, each additional hour |
| 36415 | Collection of venous blood by venipuncture |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis, initial hour |
| 99214 | Established patient office visit, moderate complexity |
Common Questions About Using ICD-10 Code D81.7 for Major histocompatibility complex class II deficiency
What are the common symptoms of Major histocompatibility complex class II deficiency?
Common symptoms include recurrent infections, failure to thrive, and autoimmune manifestations. Patients may experience frequent respiratory illnesses and require hospitalization for severe infections.
How is Major histocompatibility complex class II deficiency diagnosed?
Diagnosis is typically made through clinical evaluation, family history, and laboratory tests that assess immune function, including T-cell counts and MHC molecule expression.
What treatment options are available for this condition?
Treatment may include intravenous immunoglobulin therapy, prophylactic antibiotics, and supportive care to manage infections and promote growth.
Is hospitalization necessary for patients with Major histocompatibility complex class II deficiency?
Yes, hospitalization may be necessary for severe infections or complications associated with this condition, particularly in infants and young children.
Clinical Notes
SOAP notes
DAP notes
AI medical notes